TTC39CP1

Across TCGA pan-cancer cohorts, TTC39CP1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated TTC39CP1 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher TTC39CP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TTC39CP1 expression acts as an unfavorable survival marker.

KICH, UCS, and STAD are the cancer types where TTC39CP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	II,III,IV	0.070	0.828	<.001	63	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
STAD	OS	Tertile	II,III,IV	0.239	0.721	<.001	27	view →
ACC	DFS	Tertile	II,III,IV	0.048	0.581	<.001	27	view →
LUAD	OS	Tertile	III,IV	0.228	0.677	.015	18	view →
KIRC	OS	Tertile	II,III,IV	0.172	0.555	.018	12	view →
SARC	DFS	Tertile	All	0.101	0.599	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

TTC39CP1–KICH (OS)

Open the KICH breakdown →